Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 150


Synergistic signals for natural cytotoxicity are required to overcome inhibition by c-Cbl ubiquitin ligase.

Kim HS, Das A, Gross CC, Bryceson YT, Long EO.

Immunity. 2010 Feb 26;32(2):175-86. doi: 10.1016/j.immuni.2010.02.004.


Minimal requirement for induction of natural cytotoxicity and intersection of activation signals by inhibitory receptors.

Bryceson YT, Ljunggren HG, Long EO.

Blood. 2009 Sep 24;114(13):2657-66. doi: 10.1182/blood-2009-01-201632. Epub 2009 Jul 23.


Vav1-phospholipase C-γ1 (Vav1-PLC-γ1) pathway initiated by T cell antigen receptor (TCRγδ) activation is required to overcome inhibition by ubiquitin ligase Cbl-b during γδT cell cytotoxicity.

Yin S, Zhang J, Mao Y, Hu Y, Cui L, Kang N, He W.

J Biol Chem. 2013 Sep 13;288(37):26448-62. doi: 10.1074/jbc.M113.484600. Epub 2013 Jul 29.


HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.

Braud VM, Allan DS, O'Callaghan CA, Söderström K, D'Andrea A, Ogg GS, Lazetic S, Young NT, Bell JI, Phillips JH, Lanier LL, McMichael AJ.

Nature. 1998 Feb 19;391(6669):795-9.


Balance between activating NKG2D, DNAM-1, NKp44 and NKp46 and inhibitory CD94/NKG2A receptors determine natural killer degranulation towards rheumatoid arthritis synovial fibroblasts.

Nielsen N, Pascal V, Fasth AE, Sundström Y, Galsgaard ED, Ahern D, Andersen M, Baslund B, Bartels EM, Bliddal H, Feldmann M, Malmström V, Berg L, Spee P, Söderström K.

Immunology. 2014 Aug;142(4):581-93. doi: 10.1111/imm.12271.


Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104.

Brando C, Mukhopadhyay S, Kovacs E, Medina R, Patel P, Catina TL, Campbell KS, Santoli D.

J Leukoc Biol. 2005 Aug;78(2):359-71. Epub 2005 Jun 3.


HLA-E protects glioma cells from NKG2D-mediated immune responses in vitro: implications for immune escape in vivo.

Wischhusen J, Friese MA, Mittelbronn M, Meyermann R, Weller M.

J Neuropathol Exp Neurol. 2005 Jun;64(6):523-8.


HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells.

King A, Allan DS, Bowen M, Powis SJ, Joseph S, Verma S, Hiby SE, McMichael AJ, Loke YW, Braud VM.

Eur J Immunol. 2000 Jun;30(6):1623-31.


Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.

Moretta A, Bottino C, Vitale M, Pende D, Cantoni C, Mingari MC, Biassoni R, Moretta L.

Annu Rev Immunol. 2001;19:197-223. Review.


XLP1 inhibitory effect by 2B4 does not affect DNAM-1 and NKG2D activating pathways in NK cells.

Meazza R, Tuberosa C, Cetica V, Falco M, Loiacono F, Parolini S, Micalizzi C, Moretta A, Mingari MC, Moretta L, Bottino C, Aricò M, Pende D.

Eur J Immunol. 2014 May;44(5):1526-34. doi: 10.1002/eji.201344312. Epub 2014 Feb 27.


NKG2D ligation relieves 2B4-mediated NK-cell self-tolerance in mice.

Lee JE, Lim SA, Kim TJ, Kim K, Ng J, Kim YH, Jang IJ, Oh SB, Lee JC, Yee C, Kumar V, Lee KM.

Eur J Immunol. 2014 Jun;44(6):1802-13. doi: 10.1002/eji.201343724. Epub 2014 Apr 16.


HMBOX1 negatively regulates NK cell functions by suppressing the NKG2D/DAP10 signaling pathway.

Wu L, Zhang C, Zhang J.

Cell Mol Immunol. 2011 Sep;8(5):433-40. doi: 10.1038/cmi.2011.20. Epub 2011 Jun 27.


Mitogen-activated protein kinase activity is involved in effector functions triggered by the CD94/NKG2-C NK receptor specific for HLA-E.

Carretero M, Llano M, Navarro F, Bellón T, López-Botet M.

Eur J Immunol. 2000 Oct;30(10):2842-8.


Inhibitory receptor signaling via tyrosine phosphorylation of the adaptor Crk.

Peterson ME, Long EO.

Immunity. 2008 Oct 17;29(4):578-88. doi: 10.1016/j.immuni.2008.07.014. Epub 2008 Oct 2.


Impaired natural killer cell self-education and "missing-self" responses in Ly49-deficient mice.

Bélanger S, Tu MM, Rahim MM, Mahmoud AB, Patel R, Tai LH, Troke AD, Wilhelm BT, Landry JR, Zhu Q, Tung KS, Raulet DH, Makrigiannis AP.

Blood. 2012 Jul 19;120(3):592-602. doi: 10.1182/blood-2012-02-408732. Epub 2012 Jun 1. Erratum in: Blood. 2013 Oct 3;122(14):2525.

Supplemental Content

Support Center